Efficacy of transcutaneous electrical acupoint stimulation for immunological non-responder in HIV/AIDS combined with amphetamine abuse: study protocol for a randomized controlled trial
Authors:
Open Access
- 24 December 2024
- journal article
- research article
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 24 (1) , 424
Abstract
BackgroundAmphetamine-type stimulant (ATS) abuse is strongly associated with an elevated risk of HIV infection and transmission. Antiretroviral therapy (ART) serves as the primary approach for managing HIV infection and AIDS progression. However, ATS abuse diminishes the efficacy of ART in HIV/AIDS patients, amplifying the vulnerability to immunological non-response (INR) and ultimately increasing the incidence rate and mortality of opportunistic infections. Currently, no effective interventions targeting INR exist. Acupuncture has demonstrated promise in bidirectionally modulating the body's immune response and may be beneficial for INR in HIV/AIDS combined with ATS abuse. Nevertheless, further research and comprehensive evaluation are imperative to substantiate these findings.MethodsThis study is a two-center, randomized, non-acupoint controlled, single-blind clinical trial. It will be conducted in two large drug rehabilitation centers in western China, involving 114 INR patients receiving ART. The participants will be randomly assigned to either the Transcutaneous Electrical Acupoint Stimulation (TEAS) + ART group or the sham-TEAS + ART group, in a 1:1 ratio. Both groups will receive a 48-week treatment. The primary outcome measure assessed after treatment is the CD4 + T cell count. Secondary outcome measures include the immune reconstitution efficiency of HIV patients, CD4/CD8 ratio, CD4 + CD45RA + and CD4 + CD45RO + counts, CD4 + CD28 + counts, CD4 + CD38 + and CD8 + CD38 + counts, CD4 + ki67 + and CD8 + ki67 + counts, JC mitochondrial membrane potential testing, the incidence of opportunistic infections, and the HIV/AIDS PRO scale. Adverse events occurring during the study observation period will be documented.DiscussionThis study will investigate the effect of TEAS on immune reconstitution in patients with amphetamine abuse and HIV infection.Trial registrationChinese Clinical Trial Registry, ChiCTR 2300076363. Registered on October 7, 2023, https://www.chictr.org.cn/.Keywords
All Related Versions
This publication has 45 references indexed in Scilit:
- Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-respondersJournal of Leukocyte Biology, 2020
- Mood, Meth, Condom Use, and Gender: Latent Growth Curve Modeling Results from a Randomized TrialAIDS and Behavior, 2018
- Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral TherapyJAMA, 2016
- The Complex Interaction Between Methamphetamine Abuse and HIV-1 PathogenesisJournal of Neuroimmune Pharmacology, 2015
- CD4/CD8 ratio: an emerging biomarker for HIVThe Lancet HIV, 2015
- Amphetamine-group substances and HIVThe Lancet, 2010
- Factors associated with event-level stimulant use during sex in a sample of older, low-income men who have sex with men in Los AngelesDrug and Alcohol Dependence, 2009
- Close association of CD8+/CD38bright with HIV‐1 replication and complex relationship with CD4+ T‐cell countCytometry Part B: Clinical Cytometry, 2008
- Methodology of superiority vs. equivalence trials and non-inferiority trialsJournal of Hepatology, 2007
- The methamphetamine epidemic: Implications for HIV prevention and treatmentCurrent HIV/AIDS Reports, 2005